This topic contains a solution. Click here to go to the answer

Author Question: Which Old World monkey is of special interest to paleoanthropologists because it lives in savannahs ... (Read 38 times)

RRMR

  • Hero Member
  • *****
  • Posts: 557
Which Old World monkey is of special interest to paleoanthropologist s because it lives in savannahs like those in which we expect ancestral humans may have lived?
 
  a. baboons
 b. chimpanzees
  c. lemurs
 d. bonobos

Question 2

Larger hominid brains required parallel improvements in diet.
 
  a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emilymalinowski12

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

a

Answer to Question 2

True




RRMR

  • Member
  • Posts: 557
Reply 2 on: Aug 11, 2018
Great answer, keep it coming :)


dyrone

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library